Meeder Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9
| Closed | – | – | 1032 |
|
|
2022
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 2174 |
|
|
2022
Q2 | – | Sell |
-17
| Closed | – | – | 2208 |
|
|
2022
Q1 | $0 | Buy |
+17
| New | – | ﹤0.01% | 2346 |
|
|
2020
Q4 | – | Sell |
-396
| Closed | -$8K | – | 1942 |
|
|
2020
Q3 | $8K | Sell |
396
-2,331
| -85% | -$47.1K | ﹤0.01% | 1429 |
|
|
2020
Q2 | $47K | Sell |
2,727
-635
| -19% | -$10.9K | ﹤0.01% | 930 |
|
|
2020
Q1 | $54K | Sell |
3,362
-744
| -18% | -$12K | ﹤0.01% | 884 |
|
|
2019
Q4 | $85K | Sell |
4,106
-4,389
| -52% | -$90.9K | 0.01% | 844 |
|
|
2019
Q3 | $97K | Buy |
8,495
+7,888
| +1,300% | +$90.1K | 0.01% | 811 |
|
|
2019
Q2 | $8K | Sell |
607
-1,711
| -74% | -$22.6K | ﹤0.01% | 1516 |
|
|
2019
Q1 | $34K | Sell |
2,318
-1,354
| -37% | -$19.9K | ﹤0.01% | 953 |
|
|
2018
Q4 | $62K | Buy |
3,672
+3,179
| +645% | +$53.7K | 0.01% | 757 |
|
|
2018
Q3 | $7K | Sell |
493
-2,888
| -85% | -$41K | ﹤0.01% | 1240 |
|
|
2018
Q2 | $80.6K | Buy |
3,381
+3,329
| +6,402% | +$79.4K | 0.01% | 662 |
|
|
2018
Q1 | $1K | Buy |
52
+2
| +4% | +$38 | ﹤0.01% | 1444 |
|
|
2017
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1557 |
|
|
2017
Q2 | – | Sell |
-902
| Closed | -$10K | – | 1690 |
|
|
2017
Q1 | $10K | Buy |
902
+454
| +101% | +$5.03K | ﹤0.01% | 857 |
|
|
2016
Q4 | $7K | Buy |
+448
| New | +$7K | ﹤0.01% | 808 |
|